Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 6/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5482787 | 1.00 | NAAA (0.47) | NAAAHCAR2EPHX1ACHETSHR | |
| SCHEMBL27843702 | 0.93 | ALDH1A1 (0.45) | NAAAHCAR2ACHETSHR | |
| SCHEMBL8623221 | 0.86 | NAAA (0.36) | NAAAHCAR2EPHX1ACHETSHR | |
| Ammonia Solution, Strong SCHEMBL27789585 | 0.85 | NAAA (0.53) | NAAAHCAR2EPHX1ACHETSHR | |
| SCHEMBL28688019 | 0.85 | HCAR2 (0.38) | HCAR2TSHR | |
| SCHEMBL28312936 | 0.83 | NAAA (0.49) | NAAAEPHX1ACHETSHRRAD52 | |
| SCHEMBL11676254 | 0.83 | MAPT (0.42) | HCAR2ACHETSHR | |
| SCHEMBL5172437 | 0.82 | CYP4F2 (0.51) | NAAAHCAR2EPHX1ACHETSHR | |
| SCHEMBL29218924 | 0.82 | CYP4F2 (0.51) | NAAAHCAR2EPHX1ACHETSHR | |
| SCHEMBL28297772 | 0.82 | CYP4F2 (0.51) | NAAAHCAR2EPHX1ACHETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020183575-A1 | Components and catalysts for the polymerization of olefins | BASELL POLIOLEFINE ITALIA S.P.A. (IT) | 2002-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183575-A1 | Components and catalysts for the polymerization of olefins | SCO2, ECI1, MT-CO2 | NAAA 4712/4885HCAR2 606/4885EPHX1 2160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.